Venture Life Group (LON:VLG) Posts Quarterly Earnings Results

Venture Life Group (LON:VLG) posted its quarterly earnings data on Tuesday. The company reported GBX 4.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.

Venture Life Group Price Performance

VLG traded up GBX 0.91 during trading on Friday, reaching GBX 69.41. The stock had a trading volume of 1,062,059 shares, compared to its average volume of 281,785. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.48 and a current ratio of 4.71. The stock has a market cap of £83.33 million, a PE ratio of 15.88, a PEG ratio of 5.67 and a beta of 0.23. The business has a 50-day moving average of GBX 67.37 and a 200-day moving average of GBX 65.08. Venture Life Group has a one year low of GBX 52 and a one year high of GBX 72.

Insider Transactions at Venture Life Group

In other Venture Life Group news, insider Daniel Wells purchased 14,760 shares of Venture Life Group stock in a transaction on Thursday, October 1st. The shares were acquired at an average cost of GBX 68 per share, for a total transaction of £10,036.80. 7.52% of the stock is currently owned by corporate insiders.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.